Profiel
Kelly Devine Deck is currently the Chief Financial Officer at Inhibrx, Inc. and a Trustee at The Fleet Science Center.
Previously, she worked as the Executive Director-Finance at Apricus Biosciences, Inc. from 2013 to 2018.
Actieve functies van Kelly Deck
Bedrijven | Functie | Begin |
---|---|---|
INHIBRX, INC. | Director of Finance/CFO | - |
Fleet Science Center | Director/Board Member | - |
Eerdere bekende functies van Kelly Deck
Bedrijven | Functie | Einde |
---|---|---|
Apricus Biosciences, Inc.
Apricus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Apricus Biosciences, Inc. is a biopharmaceutical company, which engages in the development and commercialization of product candidates in the areas of specialty urology and rheumatology. Its products include Vitaros and Femprox. The company was founded in 1987 and is headquartered in San Diego, CA. | Director of Finance/CFO | 01-01-2018 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
INHIBRX, INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Apricus Biosciences, Inc.
Apricus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Apricus Biosciences, Inc. is a biopharmaceutical company, which engages in the development and commercialization of product candidates in the areas of specialty urology and rheumatology. Its products include Vitaros and Femprox. The company was founded in 1987 and is headquartered in San Diego, CA. | Health Technology |
Fleet Science Center |